Examining the Validity of External Controls Relative to Randomized Controls
This presentation discusses the validity of external controls in medical product development and their comparison to randomized controls.
- Publisher
- European Medicines Agency (EMA)
- Length
- 19 pages
- File
- 5.0 MB PDF
⬇
Download the full 19-page PDF
Free · 5.0 MB · Instant access after email
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
Barriers and Facilitators to Use of Digital Health Tools by Healthcare Practitioners
This study identifies key barriers and facilitators impacting healthcare practitioners' use of digital health technologies during and before the COVID-19 pandemic.
🔒 La Negoziazione del Prezzo dei Farmaci Oncologici in Italia
This whitepaper analyzes the market benchmark role in negotiating oncology drug prices in Italy, highlighting key implications for clinical practice.
Radiopharmaceuticals - EU-IN Horizon Scanning Report
This report outlines the current status, trends, and regulatory challenges in the field of radiopharmaceuticals in the EU.